Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases.

Lu WangErica A VossJames WeaverLaura HesterZhong YuanFrank DeFalcoMartijn J SchuemiePatrick B RyanDon SunAmy FreedmanMaria AlbaJoan LindGary MeiningerJesse A BerlinNorman Rosenthal

Published in: Pharmacoepidemiology and drug safety (2019)

Increased risk of DKA was observed for new users of SGLT2i versus several non-SGLT2i AHAs when T2DM was defined broadly. When T2DM was defined narrowly to exclude possible misclassified patients, an increased risk of DKA with SGLT2i was observed compared with sulfonylureas.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
health insurance
patient reported outcomes
machine learning
skeletal muscle
big data
deep learning
adipose tissue
artificial intelligence
patient reported